Response to mRNA SARS‐CoV‐2 vaccination evaluated by B‐cell receptor repertoire after tixagevimab/cilgavimab administration
暂无分享，去创建一个
G. Ohji | Katsuya Yamamoto | H. Minami | T. Matsutani | N. Kiyota | A. Kitao | K. Yakushijin | S. Kawamoto | Y. Imamura | Y. Funakoshi | Shiro Kimbara | T. Koyama | Y. Nagatani | H. Sakai | S. Matsumoto | M. Watanabe | W. Hojo | M. Ito | Yasuyuki Saito | Taiji Koyama | S. Kimbara